Combination of antiangiogenic therapy using the mTOR inhibitor RAD001 (everolimus) and low-dose chemotherapy for locally advanced and/or metastatic pancreatic cancer: Dose-finding study.
Mareile Joka
No relevant relationships to disclose
Stefan Hubert Boeck
No relevant relationships to disclose
Christian Hosius
No relevant relationships to disclose
Laetitia Decroix
No relevant relationships to disclose
Christoph May
No relevant relationships to disclose
Barbara Alberter
No relevant relationships to disclose
Anette Pustowka
No relevant relationships to disclose
Volker Heinemann
No relevant relationships to disclose
Christiane Bruns
No relevant relationships to disclose